CTOs on the Move


 
Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Exthera Medical

Exthera Medical is a Berkeley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HealthSCOPE Benefits

HealthSCOPE Benefits is committed to maintain the exclusive focus of managinghealthcare costs for client companies, to provide unsurpassed customer serviceand seamless benefits administration, managed care, and informatics servicesand to support client

Prime Medica

Prime Medica is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Healthcare Informatics Associates

Healthcare Informatics Associates is a Bainbridge Island, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Oj Medtech Inc

Oj Medtech Inc is a Bay Shore, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.